Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-02
2011-11-15
Spivack, Phyllis G. (Department: 1629)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
08058303
ABSTRACT:
Provided is a pharmaceutical composition for external use which includes the following components: 1) luliconazole and/or a salt thereof; 2) N-methyl-2-pyrollidone; and 3) benzyl alcohol and/or diester of a dibasic acid. The diester of the dibasic acid is a diethyl ester or a diisopropyl ester of a dibasic acid having 6-10 carbon atoms. The pharmaceutical composition is useful for the treatment of a mycotic disease such as foot trichophytosis, trichophytosis corporis, trichophytosis on a hard keratin or hyperkeratotic portion, onychomycosis, particularly on a nail, or dermatomycosis.
REFERENCES:
patent: 4764381 (1988-08-01), Bodor et al.
patent: 5753256 (1998-05-01), Cordes et al.
patent: 5993787 (1999-11-01), Sun et al.
patent: 6017920 (2000-01-01), Kamishita et al.
patent: 6083518 (2000-07-01), Lindahl
patent: 6428654 (2002-08-01), Cronan, Jr. et al.
patent: 6585963 (2003-07-01), Quan et al.
patent: 6740326 (2004-05-01), Meyer et al.
patent: 2003/0235541 (2003-12-01), Maibach et al.
patent: 2004/0208906 (2004-10-01), Tatara et al.
patent: 2005/0232879 (2005-10-01), Sasagawa et al.
patent: 2006/0140984 (2006-06-01), Tamarkin et al.
patent: 2008/0031835 (2008-02-01), Kawamura et al.
patent: 2009/0030059 (2009-01-01), Miki et al.
patent: 2009/0076109 (2009-03-01), Miki et al.
patent: 2009/0137651 (2009-05-01), Kobayashi et al.
patent: 2009/0202602 (2009-08-01), Ishima et al.
patent: 2010/0168200 (2010-07-01), Masuda et al.
patent: 2010/0173965 (2010-07-01), Masuda et al.
patent: 2010/0204293 (2010-08-01), Masuda et al.
patent: 1 138 314 (2001-10-01), None
patent: 1 522 316 (2005-04-01), None
patent: 1 537 868 (2005-06-01), None
patent: 62-093227 (1987-04-01), None
patent: 01-242525 (1989-09-01), None
patent: 01-246219 (1989-10-01), None
patent: 02-264723 (1990-10-01), None
patent: 02-275877 (1990-11-01), None
patent: 05-306223 (1993-11-01), None
patent: 06-199701 (1994-07-01), None
patent: 06-211651 (1994-08-01), None
patent: 07-206711 (1995-08-01), None
patent: 07-223971 (1995-08-01), None
patent: 08-020527 (1996-01-01), None
patent: 10-152433 (1998-06-01), None
patent: 10-226639 (1998-08-01), None
patent: 10-226686 (1998-08-01), None
patent: 2001-064206 (2001-03-01), None
patent: 2002-114680 (2002-04-01), None
patent: 2002-193755 (2002-07-01), None
patent: 2002-363070 (2002-12-01), None
patent: 2003-252798 (2003-09-01), None
patent: 2004-529923 (2004-09-01), None
patent: 2005-154306 (2005-06-01), None
patent: 2005-289879 (2005-10-01), None
patent: 2 270 894 (2004-03-01), None
patent: WO 95/30440 (1995-11-01), None
patent: WO 96/11710 (1996-04-01), None
patent: WO 96/40047 (1996-12-01), None
patent: WO 97/02821 (1997-01-01), None
patent: WO 00/01384 (2000-01-01), None
patent: WO 02/062336 (2002-08-01), None
patent: WO 02/083084 (2002-10-01), None
patent: WO 02/087570 (2002-11-01), None
patent: WO 03/020248 (2003-03-01), None
patent: WO 03/105841 (2003-12-01), None
patent: WO 2004/021968 (2004-03-01), None
patent: WO 2004/084826 (2004-10-01), None
patent: WO 2005/099764 (2005-10-01), None
patent: WO 2005/123136 (2005-12-01), None
patent: WO 2006/038317 (2006-04-01), None
patent: WO 2007/077806 (2007-07-01), None
patent: WO 2007077806 (2007-07-01), None
patent: WO 2007/102242 (2007-09-01), None
patent: WO 2007/077806 (2007-12-01), None
Niwano, et al. “Efficacy of NND-502, a Novel Imidazole Antimycotic Agent, in Experimental Models ofCandida albicansandAspergillus fumigatusInfections,”International Journal of Antimicrobial Agents, vol. 12, pp. 221-228, 1999.
Uchida, et al. “In vitro Antifungal Activity of Luliconazole (NND-502), a Novel Imidazole Antifungal Agent,”J. Infect Chemother., vol. 10, pp. 216-219, 2004.
Uchida, et al. “In vitro Activity of Novel Imidazole Antifungal Agent NND-502 AgainstMalasseziaspecies,”International Journal of Antimicrobial Agents, vol. 21, pp. 234-238, 2003.
Borrás-Blasco, et al. “A Mathematical Approach to Predicting the Percutaneous Absorption Enhancing Effect of Sodium Lauryl Sulphate,”International Journal of Pharmaceutics, vol. 269, pp. 121-129, 2004.
Martins, et al. “In vitro Sensitivity of Dermatophytes to Urea,”Clinics, vol. 61, No. 1, pp. 9-14, 2006.
Uchida, et al. “In vitro Antifungal Activity of Luliconazole (NND-502), a Novel Imidazole Antifungal Agent,”Journal of Infectious Chemotherapy, vol. 10, pp. 216-219, 2004.
Article, “Treatment” in 2 pages downloaded from http://www.babymd,net/dryskin.htm date unknown, 2011.
Niwano, et al. “In Vitro and In Vivo Antidermatophyte Activities of NND-4502, a Novel Optically Active Imidazole Antimycotic Agent,”Antimicrobial Agents and Chemotherapy, vol. 42, No. 4, pp. 967-970, Apr. 1998.
Fujii Hiroyuki
Kobayashi Hirokazu
Miki Toyohiko
Nozawa Akira
Knobbe Martens Olson & Bear LLP
Nihon Nohyaku Co, Ltd
Pola Pharma Inc
Spivack Phyllis G.
LandOfFree
Pharmaceutical composition for external use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition for external use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for external use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4306714